Risk of Fetal Exposure to Folic Acid Antagonists

Journal of Obstetrics and Gynaecology Canada

Volumn 26, Issue 5, 2004, Pages 475-479

  Wen, Shi Wu ^a,b   Walker, Mark ^a,b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

Author keywords

Abnormalities; Drug; Fetus; Folic acid antagonists; Pregnancy; Prescriptions

Indexed keywords

FOLIC ACID ANTAGONIST;

ADOLESCENT; ADULT; CHEMICALLY INDUCED DISORDER; CONGENITAL MALFORMATION; FEMALE; FETOMATERNAL TRANSFUSION; FETUS; FETUS DEATH; GESTATIONAL AGE; HUMAN; PREGNANCY; PRESCRIPTION; REVIEW; RISK FACTOR;

ABNORMALITIES, DRUG-INDUCED; ADOLESCENT; ADULT; FEMALE; FETAL DEATH; FETUS; FOLIC ACID ANTAGONISTS; GESTATIONAL AGE; HUMANS; MATERNAL-FETAL EXCHANGE; PREGNANCY; PRESCRIPTIONS, DRUG; RISK FACTORS;

EID: 3242683612     PISSN: 17012163     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1701-2163(16)30658-2     Document Type: Article

References (20)

1. Clark WG, Brater DC, Johnson AR Goth's medical pharmacology 1992, Mosby Year Book, St. Louis (MO.
2. Lambie DG, Johnson RH Drugs and folate metablism. Drugs 1985, 30:145-155.
3. Briggs GG, Freeman RK, Yaffe SJ Drugs in pregnancy and lactation 2002, Lippincott Williams & Wilkins, Philadelphia (PA.
4. Barron WM, Lindheimer MD Preface and guidelines for prescribing drugs to pregnant women. Lindheimer MD Medical disorders during pregnancy 1991, ix-xii. Mosby Year Book, St Louis (MO). W.M. Barron (Ed.).
5. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 2000, 343:1608-1614.
6. Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA Neural tube defects in relation to use of folic acid antagonists during pregnancy. Am J Epidemiol 2001, 153:961-968.
7. Finnell RH, Bielec B, Nau H Anticonvulsant drugs: mechanisms and pathogenesis of teratogenicity. Drug toxicity in embryonic development II: advances in understanding mechanisms of birth defects: mechanistic understanding of human developmental toxicants. Handbook of experimental pharmacology. Vol 124/11 1997, 121-159. Springer-Verlag, Berlin, Germany. R.J. Kavlock, G.P. Daston (Eds.).
8. Downey W, Beck P, McNutt M, Stang MR, Osei W, Nichol J Health databases in Saskatchewan. Pharmacoepidemiology 2000, 325-345. John Wiley & Sons, Chichester (England). B.L. Strom (Ed.).
9. Benirschke K Normal development. Maternal-fetal medicine 1999, 63-71. W B. Saunders, Philadelphia. R.K. Creasy, R. Resnik (Eds.).
10. Friso S Choi SW Gene-nutrient interactions and DNA methylation. J Nutr 2002, 132(8 Suppl):2382S-2387S.
11. Czeizel AE Prevention of congenital abnormalities by periconceptional multivitamin supplementation. BMJ 1993, 306(6893):1645-1648.
12. Czeizel AE, Dudas I Prevention of the first occurrence of neural-tube defects by periconceptional vitamin supplementation. N Engl J Med 1992, 327(26):1832-1835.
13. Shaw GM, Wasserman O'Malley CD, CR Tolarova MM, Lammer EJ Maternal periconceptional use of multivitamins and reduced risk for conotruncal heart defects and limb deficiencies among offspring. Am J Med Genet 1995, 59(4):536-545.
14. Duthie SJ, Hawdon A DNA instability (strand breakage, uracil misincor-poration. and defective repair) is increased by folic acid depletion in human lymphocytes in vitro. FASEB J 1998, 12:1491-1497.
15. Steegers-Theunissen RPM, Smith SC, Steegers EAP, Guilbert LJ, Baker PN Folate affects apoptosis in human trophoblastic cells. Br J Obstet Gynecol 2000, 107:1513-1515.
16. Autret E, Radal MJonville-Bera AP, Goehrs JM Isotretinoin in women of childbearing age: failure of following prescription guidelines. Ann Dermatol Venereol 1997, 124:518-522.
17. Honein MA, Paulozzi LJ, Cragan JD, Correa A Evaluation of selected characteristics of pregnancy drug registries. Teratology 1999, 60:356-364.
18. Pastuszak A, Koren G, Milich V Prospective assessment of pregnancy outcome following first-trimester exposure to benzodiazepines. Maternal and fetal toxicology 1994, 77-88. Marcel Dekker, New York. G. Koren (Ed.).
19. Vallance P Drugs and the fetus. BMJ 1996, 312:1053-1054.
20. Czeizel AE Recommendation to avoid all drugs during first trimester is unrealistic. BMJ 1996, 313:424-425.